Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2021-09-01–present
Board Member
Biocryst Pharmaceuticals Inc (BCRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Biocryst Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get BCRX alertsSteven Galson is recorded as Board Member at Biocryst Pharmaceuticals Inc (BCRX) since September 1, 2021. Biocryst Pharmaceuticals Inc reported in an 8-K filed August 26, 2021 that Steven Galson was appointed director, effective September 1, 2021. Biocryst Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Biocryst Pharmaceuticals Inc includes Charles Gayer (CEO and Board Member), Charlie Gayer (CEO and Board Member), Vincent J. Milano (Chairman and Board Member) and 7 others.
“On August 24, 2021, the Board of Directors (the “Board”) of BioCryst Pharmaceuticals, Inc. (the “Company”) voted to increase the size of the Board from nine directors to ten directors and elected Steven Galson, M.D. to fill the vacancy created by the enlargement of the Board, effective September 1, 2021 (the “Effective Date”).”
2021-09-01–present
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2021-09-01–present